{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:19Z","timestamp":1789632199803,"version":"build-2803163510"},"reference-count":92,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15841","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:10:41Z","timestamp":1788347441000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Ming-Yue","family":"Du","sequence":"first","affiliation":[{"name":"Department of Medical Ultrasound, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-E","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasound, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"key20260917101346_b1-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1470-2045(25)00730-2","article-title":"Global, regional, and national burden of breast cancer among females, 1990\u20132023, with forecasts to 2050: A systematic analysis for the Global Burden of Disease Study 2023","volume":"27","author":"GBD 2023 Breast Cancer Collaborators","year":"2026","journal-title":"Lancet Oncol"},{"key":"key20260917101346_b2-ol-32-4-15841","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"key20260917101346_b3-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: New perspectives 2006","volume":"18","author":"Kaufmann","year":"2007","journal-title":"Ann Oncol"},{"key":"key20260917101346_b4-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/jama.2009.1450","article-title":"Surgeon recommendations and receipt of mastectomy for treatment of breast cancer","volume":"302","author":"Morrow","year":"2009","journal-title":"JAMA"},{"key":"key20260917101346_b5-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.ejso.2023.03.225","article-title":"A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy","volume":"49","author":"Gulis","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"key20260917101346_b6-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jncimonographs\/lgv020","article-title":"Surgical considerations after neoadjuvant chemotherapy: Breast conservation therapy","volume":"2015","author":"Buchholz","year":"2015","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key20260917101346_b7-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.2007.15.3510","article-title":"Preoperative therapy in invasive breast cancer: Pathologic assessment and systemic therapy issues in operable disease","volume":"26","author":"Gralow","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b8-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"key20260917101346_b9-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive Meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"key":"key20260917101346_b10-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"443","DOI":"10.5144\/0256-4947.2013.443","article-title":"Pathological responses and long-term outcome analysis after neoadjuvant chemotheraphy in breast cancer patients from Kuwait over a period of 15 years","volume":"33","author":"Krishnan","year":"2013","journal-title":"Ann Saudi Med"},{"key":"key20260917101346_b11-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20260917101346_b12-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/cancers18111718","article-title":"Pathological complete response after neoadjuvant chemotherapy in breast cancer: A literature overview","volume":"18","author":"Gorzelak-Magiera","year":"2026","journal-title":"Cancers (Basel)"},{"key":"key20260917101346_b13-ol-32-4-15841","first-page":"e40066","article-title":"Luminal B, human epidermal growth factor receptor 2 (HER2\/neu), and Triple-Negative breast cancers associated with a better chemotherapy response than luminal A breast cancers in postneoadjuvant settings","volume":"15","author":"Hashmi","year":"2023","journal-title":"Cureus"},{"key":"key20260917101346_b14-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","article-title":"Role of imaging in neoadjuvant therapy for breast cancer","volume":"22","author":"Dialani","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20260917101346_b15-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1200\/JCO.2011.41.3161","article-title":"Defining the benefits of neoadjuvant chemotherapy for breast cancer","volume":"30","author":"Schott","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b16-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.2147\/DDDT.S253961","article-title":"Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"key20260917101346_b17-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clinimag.2021.03.039","article-title":"Molecular markers, pathology, and ultrasound features of invasive breast cancer","volume":"79","author":"Huang","year":"2021","journal-title":"Clin Imaging"},{"key":"key20260917101346_b18-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s10278-025-01388-8","article-title":"Classification of molecular subtypes of breast cancer using radiomic features of preoperative ultrasound images","volume":"38","author":"Zhang","year":"2025","journal-title":"J Imaging Inform Med"},{"key":"key20260917101346_b19-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/ijc.29323","article-title":"Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer","volume":"136","author":"Marinovich","year":"2015","journal-title":"Int J Cancer"},{"key":"key20260917101346_b20-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.breast.2022.01.006","article-title":"Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer","volume":"62","author":"Harbeck","year":"2022","journal-title":"Breast"},{"key":"key20260917101346_b21-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1169010","DOI":"10.3389\/fonc.2023.1169010","article-title":"Neoadjuvant chemotherapy for breast cancer: An evaluation of its efficacy and research progress","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"key20260917101346_b22-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/ijms20112655","article-title":"Estrogen receptor positive breast cancer with high expression of androgen receptor has less cytolytic activity and worse response to neoadjuvant chemotherapy but better survival","volume":"20","author":"Okano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20260917101346_b23-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.breast.2021.07.019","article-title":"Dissecting the biological heterogeneity of HER2-positive breast cancer","volume":"59","author":"Schettini","year":"2021","journal-title":"Breast"},{"key":"key20260917101346_b24-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/annonc\/mdy547","article-title":"Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy","volume":"30","author":"Luen","year":"2019","journal-title":"Ann Oncol"},{"key":"key20260917101346_b25-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1186\/s40001-025-03468-5","article-title":"Prediction model incorporating dynamic changes in serum tumor markers for evaluating the efficacy of neoadjuvant chemotherapy in patients with breast cancer: A retrospective cohort study","volume":"30","author":"Li","year":"2025","journal-title":"Eur J Med Res"},{"key":"key20260917101346_b26-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/BD-229004","article-title":"Correlation analysis of HIF-1\u03b1 and Ca15-3 in response to neoadjuvant chemotherapy in locally advanced breast cancer: A cohort study in Indonesia","volume":"41","author":"Manginstar","year":"2022","journal-title":"Breast Dis"},{"key":"key20260917101346_b27-ol-32-4-15841","first-page":"567301","article-title":"A retrospective analysis of a serum multi-biomarker (CA153, TSGF, and CYFRA 21-1) logistic regression model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer","volume":"18","author":"He","year":"2026","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"key20260917101346_b28-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12094-025-04031-8","article-title":"Exploratory evaluation of CA 15-3 \u00d7 NLR score for predicting pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"28","author":"Eniseler","year":"2026","journal-title":"Clin Transl Oncol"},{"key":"key20260917101346_b29-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jso.25125","article-title":"High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy","volume":"118","author":"Fujimoto","year":"2018","journal-title":"J Surg Oncol"},{"key":"key20260917101346_b30-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.breast.2018.02.028","article-title":"Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients","volume":"39","author":"Baumgartner","year":"2018","journal-title":"Breast"},{"key":"key20260917101346_b31-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN Guidelines insights: Breast cancer, version 1.2017","volume":"15","author":"Gradishar","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"key20260917101346_b32-ol-32-4-15841","first-page":"743","article-title":"Clinicopathological characteristics related to Miller\/Payne grading system of breast carcinoma after neoadjuvant therapy and establishment of novel prediction models","volume":"51","author":"Hou","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"key20260917101346_b33-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies-improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"key20260917101346_b34-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/tbcr-24-24","article-title":"St. Gallen international breast cancer conferences & Consensus","volume":"5","author":"Th\u00fcrlimann","year":"2024","journal-title":"Transl Breast Cancer Res"},{"key":"key20260917101346_b35-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/tbcr-22-21","article-title":"Chinese society of clinical oncology (CSCO) Breast cancer guidelines 2022","volume":"3","author":"Jiang","year":"2022","journal-title":"Transl Breast Cancer Res"},{"key":"key20260917101346_b36-ol-32-4-15841","first-page":"2021","article-title":"Updated interpretation for early breast cancer in The Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines","volume":"2","author":"Shen","year":"2021","journal-title":"TBCR"},{"key":"key20260917101346_b37-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","article-title":"Eighth edition of the AJCC cancer staging manual: Breast cancer","volume":"25","author":"Giuliano","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"key20260917101346_b38-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: Breast MRI and US in patients with Node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"key":"key20260917101346_b39-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"key20260917101346_b40-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1200\/JCO.2003.05.208","article-title":"Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?","volume":"21","author":"Ring","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b41-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"key20260917101346_b42-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b43-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1200\/JCO.1998.16.1.93","article-title":"Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute","volume":"16","author":"Bonadonna","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b44-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","article-title":"Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: A cross-sectional and longitudinal study","volume":"11","author":"\u0160tork\u00e1nov\u00e1","year":"2021","journal-title":"Sci Rep"},{"key":"key20260917101346_b45-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"101562","DOI":"10.1016\/j.eclinm.2022.101562","article-title":"Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study","volume":"52","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"key20260917101346_b46-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"31644","DOI":"10.1038\/s41598-024-80409-y","article-title":"Dynamic ultrasound-based modeling predictive of response to neoadjuvant chemotherapy in patients with early breast cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"key20260917101346_b47-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"e20171","DOI":"10.7717\/peerj.20171","article-title":"Prediction of pathological complete response to neoadjuvant chemotherapy for invasive breast cancers based on longitudinal ultrasound and superb microvascular imaging: A single-center retrospective study","volume":"13","author":"Zuo","year":"2025","journal-title":"PeerJ"},{"key":"key20260917101346_b48-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.3390\/cancers13143546","article-title":"Quantitative assessment of the echogenicity of a breast tumor predicts the response to neoadjuvant chemotherapy","volume":"13","author":"Dobruch-Sobczak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20260917101346_b49-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"910869","DOI":"10.3389\/fonc.2023.910869","article-title":"Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response","volume":"13","author":"Xu","year":"2023","journal-title":"Front Oncol"},{"key":"key20260917101346_b50-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.7863\/jum.2012.31.10.1531","article-title":"Sonographic features of triple-negative and non-triple-negative breast cancer","volume":"31","author":"Wojcinski","year":"2012","journal-title":"J Ultrasound Med"},{"key":"key20260917101346_b51-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20260917101346_b52-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1148\/radiol.2021203871","article-title":"Factors affecting pathologic complete response following neoadjuvant chemotherapy in breast cancer: Development and validation of a predictive nomogram","volume":"299","author":"Kim","year":"2021","journal-title":"Radiology"},{"key":"key20260917101346_b53-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1002\/cncr.33604","article-title":"Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer","volume":"127","author":"Adrada","year":"2021","journal-title":"Cancer"},{"key":"key20260917101346_b54-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s12282-021-01220-5","article-title":"Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer","volume":"28","author":"Ochi","year":"2021","journal-title":"Breast Cancer"},{"key":"key20260917101346_b55-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-025-01978-y","article-title":"Ultrasound-based quantitative microvasculature imaging for early prediction of response to neoadjuvant chemotherapy in patients with breast cancer","volume":"27","author":"Sabeti","year":"2025","journal-title":"Breast Cancer Res"},{"key":"key20260917101346_b56-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1026647","DOI":"10.3389\/fonc.2022.1026647","article-title":"Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer","volume":"12","author":"Guo","year":"2022","journal-title":"Front Oncol"},{"key":"key20260917101346_b57-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.1088\/0031-9155\/60\/19\/7763","article-title":"Effectiveness of evaluating tumor vascularization using 3D power Doppler ultrasound with high-definition flow technology in the prediction of the response to neoadjuvant chemotherapy for T2 breast cancer: A preliminary report","volume":"60","author":"Shia","year":"2015","journal-title":"Phys Med Biol"},{"key":"key20260917101346_b58-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.ultrasmedbio.2019.08.016","article-title":"Diagnostic performance using automated breast ultrasound system for breast cancer in chinese women aged 40 Years or older: A comparative study","volume":"45","author":"Zhang","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"key20260917101346_b59-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/cancers16020377","article-title":"Elasticity values as a predictive modality for response to neoadjuvant chemotherapy in breast cancer","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20260917101346_b60-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/jcu.23951","article-title":"Research of ultrasonic shear wave elastography in evaluating the efficiency of neoadjuvant chemotherapy for breast cancer","volume":"53","author":"Luo","year":"2025","journal-title":"J Clin Ultrasound"},{"key":"key20260917101346_b61-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12282-021-01327-9","article-title":"Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: Where and when to measure is optimal?","volume":"29","author":"Gu","year":"2022","journal-title":"Breast Cancer"},{"key":"key20260917101346_b62-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.18650","article-title":"Ultrasound Elastography: Review of techniques and clinical applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics"},{"key":"key20260917101346_b63-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"120030","DOI":"10.1016\/j.cca.2024.120030","article-title":"An overview about biomarkers in breast cancer: Insights into the diagnostic and prognostic significance","volume":"567","author":"Emanuelle Pereira Santos","year":"2025","journal-title":"Clin Chim Acta"},{"key":"key20260917101346_b64-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pathol.2023.10.014","article-title":"Predictive and prognostic biomarkers in breast tumours","volume":"56","author":"Krystel-Whittemore","year":"2024","journal-title":"Pathology"},{"key":"key20260917101346_b65-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00595-019-01858-x","article-title":"Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy","volume":"50","author":"Iwamoto","year":"2020","journal-title":"Surg Today"},{"key":"key20260917101346_b66-ol-32-4-15841","first-page":"351","article-title":"Clinicopathological factors predicting pathological complete response to neoadjuvant Anti-HER2 therapy in HER2-positive breast cancer","volume":"103","author":"Jung","year":"2025","journal-title":"Oncology"},{"key":"key20260917101346_b67-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1157\/13112363","article-title":"Preoperative CA15.3 serum levels and cellular proliferation in patients having infiltrating ductal carcinomas of the breast","volume":"26","author":"Ruibal","year":"2007","journal-title":"Rev Esp Med Nucl"},{"key":"key20260917101346_b68-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10549-019-05357-y","article-title":"The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: Data from the Korean Breast Cancer Society Registry","volume":"177","author":"Nam","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101346_b69-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/CAD.0b013e3282f3d018","article-title":"Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients","volume":"19","author":"Bao","year":"2008","journal-title":"Anticancer Drugs"},{"key":"key20260917101346_b70-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10549-018-4730-1","article-title":"Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: A retrospective study of 1010 patients","volume":"170","author":"Chen","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101346_b71-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10549-014-3197-y","article-title":"Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: Its correlation with pathological complete response to neoadjuvant chemotherapy","volume":"148","author":"Miyashita","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101346_b72-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10549-018-4985-6","article-title":"Impact of topoisomerase II\u03b1, PTEN, ABCC1\/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy","volume":"173","author":"Guestini","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101346_b73-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2217\/fon-2016-0420","article-title":"The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: A systematic review and meta-analysis","volume":"13","author":"Chen","year":"2017","journal-title":"Future Oncol"},{"key":"key20260917101346_b74-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2017.08.022","article-title":"Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice","volume":"153","author":"Wong","year":"2017","journal-title":"Gastroenterology"},{"key":"key20260917101346_b75-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/cancers16132421","article-title":"Breast cancer Patient's outcomes after neoadjuvant chemotherapy and surgery at 5 and 10 years for stage II\u2013III disease","volume":"16","author":"Falo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20260917101346_b76-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"key20260917101346_b77-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"key20260917101346_b78-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11845-023-03489-1","article-title":"Association of clinical biomarkers and response to neoadjuvant therapy in breast cancer","volume":"193","author":"Feeney","year":"2024","journal-title":"Irish J Med Sci"},{"key":"key20260917101346_b79-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20260917101346_b80-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"107280","DOI":"10.1016\/j.esmoop.2026.107280","article-title":"329eP Predictors of pathological complete response following neoadjuvant chemotherapy in breast cancer: A real-world analysis","volume":"11","author":"Castro","year":"2026","journal-title":"ESMO Open"},{"key":"key20260917101346_b81-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20260917101346_b82-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"e47070","DOI":"10.1097\/MD.0000000000047070","article-title":"Clinical value of ultrasound combined with the nutritional risk index in predicting the efficacy of neoadjuvant chemotherapy for breast cancer: An observational study","volume":"105","author":"Liu","year":"2026","journal-title":"Medicine (Baltimore)"},{"key":"key20260917101346_b83-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00330-021-08293-y","article-title":"Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: A prospective study","volume":"32","author":"Gu","year":"2022","journal-title":"Eur Radiol"},{"key":"key20260917101346_b84-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.tranon.2024.101985","article-title":"The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and Pathomics signatures based on machine learning and deep learning","volume":"46","author":"Jiang","year":"2024","journal-title":"Transl Oncol"},{"key":"key20260917101346_b85-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13058-022-01580-6","article-title":"An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: A multicentre, retrospective study","volume":"24","author":"Wu","year":"2022","journal-title":"Breast Cancer Res"},{"key":"key20260917101346_b86-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"issue":"v","key":"key20260917101346_b87-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0033-8389(01)00017-3","article-title":"Breast imaging reporting and data system (BI-RADS)","volume":"40","author":"Liberman","year":"2002","journal-title":"Radiol Clin North Am"},{"key":"key20260917101346_b88-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"20230370","DOI":"10.1259\/bjr.20230370","article-title":"Combined conventional ultrasonography with clinicopathological features to predict axillary status after neoadjuvant therapy for breast cancer: A case-control study","volume":"96","author":"Yan","year":"2023","journal-title":"Bri J Radiol"},{"key":"key20260917101346_b89-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cncr.35248","article-title":"An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation","volume":"130","author":"Zheng","year":"2024","journal-title":"Cancer"},{"key":"key20260917101346_b90-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"845823","DOI":"10.3389\/fonc.2022.845823","article-title":"Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"key20260917101346_b91-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13643-024-02520-5","article-title":"Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: A systematic review and meta-analysis","volume":"13","author":"Bahrin","year":"2024","journal-title":"Syst Rev"},{"key":"key20260917101346_b92-ol-32-4-15841","doi-asserted-by":"publisher","first-page":"11795549231195293","DOI":"10.1177\/11795549231195293","article-title":"The value of neoadjuvant anthracycline-based regimens for HER2-positive breast cancer: A systematic review and meta-analysis including 1366 patients","volume":"17","author":"Ding","year":"2023","journal-title":"Clin Med Insights Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:14:48Z","timestamp":1789629288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15841","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}